Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors

MAO-B inhibitors are frequently used in the treatment of neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Due to the limited number of compounds available in this field, there is a need to develop new compounds. In the recent works, it was shown that various thiosemicarbazone derivati...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Derya Osmaniye, Berkant Kurban, Begüm Nurpelin Sağlık, Serkan Levent, Yusuf Özkay, Zafer Asım Kaplancıklı
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
Accès en ligne:https://doaj.org/article/cfe17d4976e34513ab429bd9d92e62c3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!